Price
7.2
+3%52W Range
Market Cap
₹36.07 Cr
Traded: ₹0.03 Cr (0.07%) 0.0x
Free Float: ₹16.72 Cr (0.16% of FF traded)
Volume · 60D trend
37.77 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
37 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -34.0% | -42.0% | -- | -95.0% | Decelerating |
| ROE | +1.0% | -8.0% | -10.0% | -- | -- | Decelerating |
| Return | -- | -35.0% | -33.0% | -24.0% | -- | Accelerating |
| Profit | -- | -- | +10.0% | -- | -547.0% | Decelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | -0 | 2 | 3 | 20 | 39 | 33 | 39 | 31 | 23 | 27 | 24 | 31 | 35 |
| Expenses | 3 | 2 | 3 | 7 | 21 | 36 | 33 | 39 | 29 | 27 | 26 | 23 | 27 | 31 |
| Operating Profit | -1 | -2 | -1 | -4 | -1 | 3 | 0 | 1 | 2 | -4 | 1 | 1 | 4 | 4 |
| OPM % | -113.0% | -- | -34.1% | -130.7% | -2.5% | 8.7% | 0.8% | 2.0% | 5.8% | -17.5% | 4.0% | 4.3% | 13.3% | 12.3% |
| Other Income | -0 | -0 | 0 | 0 | -20 | -22 | 9 | 2 | 0 | -9 | 0 | 0 | 0 | -19 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 |
| Depreciation | 2 | 1 | 2 | 2 | 2 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| Profit Before Tax | -3 | -4 | -2 | -6 | -23 | -22 | 6 | -1 | -2 | -16 | -2 | -2 | 1 | -19 |
| Tax % | 3.2% | 4.8% | 5.8% | 10.0% | -6.3% | -35.4% | 7.1% | 146.6% | 46.8% | -4.2% | -29.6% | -99.0% | 580.6% | -21.9% |
| Net Profit | -4 | -4 | -3 | -6 | -21 | -14 | 5 | -3 | -3 | -15 | -1 | -0 | -5 | -15 |
| Exceptional Items | -0 | -0 | 0 | 0 | -21 | -24 | 8 | 0 | 0 | -9 | 0 | 0 | 0 | -20 |
| EPS (Rs) | -0.7 | -0.8 | -0.5 | -1.3 | -4.2 | -2.9 | 1.1 | -0.6 | -0.5 | -3.0 | -0.3 | 0.0 | -1.0 | -3.0 |
| Sales Growth (YoY) | -93.8% | -100.3% | -93.3% | -92.2% | -35.1% | 71.5% | 24.1% | 62.1% | 0.9% | -35.4% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 1046.2% | -105.9% | -28.1% | -84.7% | -48.9% | 18.3% | -16.0% | 27.7% | 35.1% | -14.4% | 9.7% | -20.5% | -13.5% | -- |
| OP Growth (YoY) | -178.0% | -162.2% | -377.8% | -606.3% | -127.8% | 185.5% | -74.5% | -24.8% | -55.6% | -191.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | 34.4% | -182.7% | 81.3% | -700.0% | -114.7% | 1163.0% | -65.8% | -56.1% | 145.1% | -476.4% | 1.0% | -74.1% | -6.7% | -- |
| Profit Growth (YoY) | -467.0% | -139.0% | -9.0% | -94.0% | 80.0% | 247.0% | -60.0% | -16050.0% | 45.0% | -233.0% | 70.0% | 100.0% | 59.0% | -40.0% |
| EPS Growth (YoY) | 83.2% | 70.9% | -146.4% | -95.3% | -681.5% | 6.6% | 479.3% | -- | 45.5% | -2.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 14.5% | -62.8% | 59.2% | 70.4% | -48.1% | -359.1% | 271.9% | -18.5% | 82.3% | -951.7% | -- | 100.0% | 66.9% | -- |
| OP Margin | -113.0% | 1630.8% | -34.1% | -130.7% | -2.5% | 8.7% | 0.8% | 2.0% | 5.8% | -17.5% | 4.0% | 4.3% | 13.3% | 12.3% |
| Net Margin | -291.1% | 3200.0% | -115.9% | -204.3% | -105.5% | -36.5% | 16.6% | -8.2% | -8.8% | -67.0% | -5.5% | -0.1% | -16.2% | -42.5% |
| Material Cost % | -- | -- | 102.7% | 180.7% | 78.4% | 72.4% | 74.1% | 79.4% | 71.5% | 81.0% | 74.8% | 67.9% | 66.4% | 71.8% |
| Employee Cost % | -- | -- | 7.3% | 25.5% | 5.9% | 3.6% | 4.4% | 4.0% | 5.3% | 6.6% | 5.8% | 6.5% | 5.5% | 4.1% |
| P/S | 5.67 | 1.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.72 | 0.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Integrated filing for Quarter ended June 30, 2026
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Closure of trading window for the quarter ended June 30, 2026
Annual Secretarial Compliance Report as on March 31st , 2026
Outcome of board meeting for the quarter ended 31st march 2026
Revised outcome of board meeting for quarter ended 31 march 2026
Related party transaction as on 31 st march 2026
Integrated filings as on 31st march, 2026
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Certificate Reg 74 (5) of SEBI (DP) Regulations , 2018 as on 31st March 2026
Declaration with respect to non- applicability of Large Entities
Closure of trading window for the quarter and year ended March 31, 2026
Integrated filing for quarter ended December 31, 2025
Results for quarter ended 31st December 2025
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today ....
Closure of trading window for the quarter ended December 31, 2025
We wish to inform you that Mrs. Mitti Jain is hereby appoitned as Company secretary and Compliance Officer of the Company
We would llike to inform you that Mr. Prathmesh Chalke tendered his resignation as Whole-time Director of the Company .
Results as on 30.09.2025
Related party transaction as on 30.09.2025
Integrated filing September 30, 2025
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....
The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025 The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Please find enclosed herewith certificate of 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended September, 30 2025 received from RTA Bigshare Services Private Limited
In terms of the subject referred the details regarding consolidated voting results of the business transacted at the 10th Annual General Meeting (AGM) of the company held on Tuesday 30th ....
Pursuant to Reg 30 SEBI (LODR), 2015 as amended we hereby submitting the summary of the proceedings of the 10 th AGM of the Company held on 30th September, 2025 at 11.00 AM and Concluded ....
This is to inform you that as per the Company''s Code for Regulating, Monitoring and Reporting of Trading by the Insiders in terms of (prohibition of Insider trading )Regulations 2015, ....
With the reference to the earlier disclosure submitted dated 29th August , 2025. We hereby submitting the revised Disclosure
Annual Report for the financial year ended March 31, 2025 along with Notice of the Tenth (10th ) Annual General Meeting and Cut-off Date for the purpose of E voting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors at their meeting held today ....
We wish to informed you members of the Company has approved by way of postal ballot the resolution as set out in the Notice of Postal Ballot dated : 01.08.2025 with requisite majority
We wish to inform you that the members of the Company has approved by the way of postal ballot , the resolution under Companies Act 2013 and SEBI Listing Regulations as set out in the Notice ....
With the reference to the Reg 30 of SEBI LODR resgulations, 2015 , we here inform you that Mrs Mitti Jain, Company Secretary and Compliance Officer of the Company has tendered her resignation ....
Integrated filing June 2025
Financials results as on June 30, 2025
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Pursuant to reg 30 SEBI (LODR) Regulations, 2015, we wolud like ti inform you about Board of Directors Meeting held today, 05th August, 2025 at 3.00 PM to 4.30 PM considered and approve ....
Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today ....
With the reference to above and in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that Mr. Ajay Sukhwani and Ms Ekta Gurnasinghani, Independent Director ....
Pursuant to Reg 30 SEBI (LODR) regulation, 2015 we enclose herewith postal ballot Notice , seeking approval of Members of the Company for below mentioned ordinary resolution
With the reference to disclosure submitted on dated 31.07.2025, we hereby submit the revised Disclosure.
With the reference to the above anf compliance with Reg 30 of SEBI (LODR) Regulations 2015, We hereby inform you that Mr. Hardesh Tolani , independent Director of the Company tender his ....
With the reference compliance with Reg 30 of SEBI (LODR) Regulations 2015, We hereby inform that Ms Manali Bhagtani has tendered her resignation as Independent Director of the Company w.e.f ....
Futher update on Factory Operations Post fire Incident
Annual Reports
9Concalls
7Aug 2021
31 Aug 2021Feb 2021
28 Feb 2021Oct 2020
31 Oct 2020Jun 2020
30 Jun 2020Jun 2018
30 Jun 2018Feb 2018
28 Feb 2018Dec 2017
31 Dec 2017